Healthcare entity
All 1 tracked stories fall under one category: regulation. Of the tracked stories, 1 of 1 also mention Candida auris, the most common co-covered peer. The 8 average consequence score is above the beat benchmark of 5.7 in the same window.
Last mentioned: Feb 27, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Of the tracked stories, 1 of 1 also mention Candida auris, the most common co-covered peer. The 8 average consequence score is above the beat benchmark of 5.7 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 3.2 for the same window. Trichophyton indotineae appears in 1 tracked Healthcare story from February 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Trichophyton indotineae. Shared-story counts are live from our verified record — not editorial picks.
New York health officials have issued a high-priority alert regarding the rapid spread of highly drug-resistant fungal infections across the state's healthcare infrastructure. These pathogens, including Candida auris, pose a severe threat to immunocompromised patients and are increasingly evading standard antifungal treatments.
Source: wgna.com · 1045theteam.com
Trichophyton indotineae is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
